CDMRP Peer Reviewed Medical Research Program: Technology/Therapeutic Development Award

The Technology/Therapeutic Development Award s a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the FY25 PRMRP Topic Areas and one of the FY25 PRMRP Strategic Goals.
 

FY25 PRMRP Topic Areas

AUTOIMMUNE DISORDERS AND IMMUNOLOGY:

• Celiac Disease

• Eczema

• Food Allergies

• Guillain-Barré Syndrome

• Inflammatory Bowel Disease

• Multiple Sclerosis

• Proteomics

• Scleroderma

CARDIOVASCULAR HEALTH

• Cardiac Health

• Congenital Heart Disease

• Proteomics

INFECTIOUS DISEASES

• Congenital Cytomegalovirus

• Far-UVC Germicidal Light

• Hepatitis B

• Malaria

• Post-Acute Sequelae of SARS CoV-2 Infection

• Proteomics

• Tick-Borne Disease

• Tuberculosis

INTERNAL MEDICINE

• Endometriosis

• Focal Segmental Glomerulosclerosis

• Interstitial Cystitis

• Menopause

• Nephrotic Syndrome

• Pancreatitis

• Polycystic Kidney Disease

• Proteomics

• Reconstructive Transplantation

• Vision

NEUROSCIENCE AND BEHAVIORAL HEALTH

• Autism

• Dystonia

• Eating Disorders

• Hydrocephalus

• Maternal Mental Health

• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

• Parkinson’s

• Peripheral Neuropathy

• Proteomics

• Sleep Disorders and Restrictions

• Suicide Prevention

• Traumatic Brain Injury and Psychological Health

ORTHOPAEDIC MEDICINE

• Orthotics and Prosthetics Outcomes

• Proteomics

RARE DISEASES AND CONDITIONS

• Angelman Syndrome

• Ehlers-Danlos Syndrome

• Epidermolysis Bullosa

• Fibrous Dysplasia/McCune-Albright Syndrome

• Fragile X

• Frontotemporal Degeneration

• Hereditary and Acquired Ataxia

• Hermansky- Pudlak Syndrome

• Mitochondrial Disease

• Myotonic Dystrophy

• Neurofibromatosis

• Proteomics

• Rett Syndrome

• Sickle-Cell Disease

• Tuberous Sclerosis Complex

• Von Hippel-Lindau Disease

RESPIRATORY HEALTH

• Burn Pit Exposure

• Proteomics

• Pulmonary Fibrosis

• Respiratory Health

It is expected that 11 awards will be granted this year. 

Funding: $2,500,000
Duration: 4 years

Research authority due date: 29.5.25

LOI (required) due date: 9.6.25
Full proposal due date: 21.7.25